EVALUATION OF EFFECTIVENESS OF THE COMBINED TREATMENT WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH CHD

被引：1
|
作者：
Kapanadze, K. [1 ]
Kipshidze, N. [1 ]
机构：
[1] Acad N Kipshidze, Natl Ctr Therapy, Tbilisi, Georgia
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70896-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
MS395
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF SIMVASTATIN ATORVASTATIN AND ATORVASTATIN-EZETIMIBE COMBINATION AMONG PATIENTS WITH DIABETES MELLITUS OR CARDIOVASCULAR DISEASE IN GENERAL PRACTICE
    Rattanakunooprakarn, H.
    Tewthanom, K.
    Sakthong, P.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A141 - A141
  • [32] EVALUATION OF THE COMPARATIVE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PATIENTS WITH HEART FAILURE
    Kamilova, U.
    Nuritdinov, N.
    [J]. ATHEROSCLEROSIS, 2020, 315 : E276 - E276
  • [33] Cost effectiveness of atorvastatin (Lipitor) as single therapy and dual therapy with ezetimibe (Zetia)
    Bui, T
    Harrison, DL
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 268 - 268
  • [34] The Effect of Combined Ezetimibe/Atorvastatin Therapy vs. Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease: A Pilot Study
    Jackowska, Paulina
    Pytel, Edyta
    Koter-Michalak, Maria
    Olszewska-Banaszczyk, Malgorzata
    Legeza, Aleksandra
    Broncel, Marlena
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (03): : 433 - 439
  • [35] Ezetimibe/Simvastatin and Atorvastatin Treatment Modify the Correlation of ApoB with LDL-C and Non-HDL-C in Patients with Metabolic Syndrome and Moderately High/High CHD Risk
    Ballantyne, Christie M.
    Grundy, Scott M.
    Hsueh, Willa A.
    Parving, Hans-Henrik
    Robinson, Jennifer G.
    Rosen, Jeffrey B.
    Lin, Jianxin
    Lowe, Robert S.
    Shah, Arvind K.
    Tershakovec, Andrew M.
    [J]. DIABETES, 2009, 58 : A180 - A180
  • [36] Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipidemia
    Kostapanos, Michael S.
    Elisaf, Moses S.
    Mikhailidis, Dimitri P.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (04) : 427 - 427
  • [37] Efficacy of ezetimibe coadminstered with simvastatin versus atorvastatin in patients with hypercholesterolemia
    Ballantyne, CM
    Blazing, MA
    King, TR
    Brady, WE
    Palmisano, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 480A - 481A
  • [38] Ezetimibe/Simvastatin Versus Atorvastatin in Metabolic Syndrome Patients with Hypercholesterolemia
    Robinson, Jennifer G.
    Ballantyne, Christie M.
    Grundy, Scott M.
    Hsueh, Willa
    Parving, Hans-Henrik
    Rosen, Jeffrey B.
    Adewale, Adeniyi J.
    Polis, Adam B.
    Tomassini, Joanne E.
    Tershakovec, Andrew M.
    [J]. DIABETES, 2009, 58 : A181 - A181
  • [39] A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol
    Niedzielski, Mateusz
    Broncel, Marlena
    Gorzelak-Pabis, Paulina
    Wozniak, Ewelina
    [J]. PLOS ONE, 2021, 16 (09):
  • [40] Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?
    Michael H Davidson
    [J]. Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 594 - 595
12345